Developing therapies to target multiple immune pathways
28 Oct 2024
Bi/Multispecifics
- Combination strategies - combining immune checkpoint inhibitors, cytokines, and immune cell-engaging antibodies.
- Finding balance between immune activation and suppression.
- Personalising therapies based on patient immune profiles to reduce adverse events?
